{
    "nctId": "NCT02739425",
    "briefTitle": "The Efficacy of Sentimag in Detection of Sentinel Node Biopsy",
    "officialTitle": "SMART Study: Sentimag Along With Routine Technique in Detection of Sentinel Node Biopsy",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Sentinel Node",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 104,
    "primaryOutcomeMeasure": "Proportion of successful sentinel node biopsies (SLNB, detection rate per patient) with either the magnetic or the standard technique",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with primary breast cancer scheduled for Sentinel node biopsy;\n* Patients who are clinically and radiologically node negative;.\n* Patients aged \u226518 years at time of consent\n* Patients are able and willing to give informed consent\n* Ability and willingness to undertake all scheduled visits and assessments\n\nExclusion Criteria:\n\n* Patients who are currently Pregnantcy or lactatingon;\n* Patients with metastatic cancer;\n* Subject has a known hypersensitivity to blue dye;\n* Patients with intolerance or hypersensitivity to iron oxide or dextran compounds;, or to Sienna+\n* Patients who have iron overload disease;\n* Patients who has a pacemaker or other implantable device in the chest wall or shoulder;\n* Previous axilla surgery, or impaired lymphatic function\n* Subject is deprived of liberty or under guardianship\n* Subject is indicated or scheduled for post-operative MRI investigation of the breast",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}